[1]JournalofMedicinalChemistry,1998,vol.41,p.5362-5374
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
25850-22-0
5397-31-9
89584-06-5
2839-90-9
1211592-87-8
167627-37-4 | 3-(4-Benzyloxyphenyl)benzoic acid | AA001XFD | MFCD06802254
168084-97-7 | 3-[(4-Bromobenzyl)oxy]benzaldehyde | AA001XPF | MFCD02815463
1685-80-9 | 2,4-Dimethylcinnamic acid | AA001Y1F | MFCD00017287
1689-82-3 | 4-(Phenyldiazenyl)phenol | AA001YA9 | MFCD00002330
1732-13-4 | 1,2,3,6,7,8-Hexahydropyrene | AA001YMO | MFCD00010584
173529-46-9 | HMN-214 | AA001YXD | MFCD12756255
173850-41-4 | ethyl 1,2-oxazole-5-carboxylate | AA001Z5D | MFCD18830699
17422-12-7 | Methyl 2-methyl-3-oxopentanoate | AA001ZFU | MFCD00184703
174603-48-6 | 3-(2-Fluoro-4-chloro-phenyl)-propionic acid | AA001ZPZ | MFCD06656906
17501-79-0 | Titanium, tetrakis(2,4-pentanedionato-κO2,κO4)- | AA00200F | MFCD00045004